Skip to main content

Global Erectile Dysfunction Treatment Drugs Market Analysis And Forecast, 2015-2025: Credence Research

According to the recent report Published by Credence Research, Inc. “Erectile Dysfunction Treatment Drugs Market (Drug Type: Phosphodiesterase type 5 inhibitor (Sildenafil (Viagra), Tadalafil (Adcirca, Cialis), Vardenafil (Levitra, Staxyn), Avanafil (Stendra)), Prostaglandin E1 (Alprostadil (Caverject, Edex, Muse, Prostin VR Pediatric)) and Others)- Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global erectile dysfunction treatment drugs market was valued at US$ 6.6 Bn in 2016, and expecting to exhibit slow growth in future years due to patent expiration of commercially available branded drugs and market entrance of generic versions of drugs.
Market Insights
Erectile dysfunction is one of the common sexual disorders affecting millions of people around the world. Various research studies show that more than half of the population aged over 40 have been suffering from erectile dysfunction. Numerous physical and psychological factors are associated with the development of erectile dysfunction and some of the risk factors are sedentary lifestyle with no physical activities, medical treatments, injuries, smoking and alcohol consumption and excessive stress.
Although there are diverse groups of treatment options available for erectile dysfunction, nonetheless medication is the most preferred among physicians augmenting improved erection by relaxing muscles and increasing blood flow. Depending on the drug type, phosphodiesterase type 5 inhibitors (PDE5 inhibitors) is estimated to be the dominating segment as a result of simple administration, minimal side-effects and its effective clinical outcomes. Viagra and Cialis faced neck-to-neck competition in terms of sales effect due to brand popularity and long-lasting effects.
Major focus of manufacturers on the future trend of medication with minimal side effects, rapid onset of action and more effective result than presently commercially available drugs is expected to propel the growth of erectile dysfunction treatment drugs market. However, market penetration of counterfeit drugs and social stigma among public regarding to the sexual issues are likely to hinder the growth of erectile dysfunction treatment drugs market.
Geographically, in the year 2016, North America is observed to be the leading region in erectile dysfunction treatment drugs market with a steady growth due to growing prevalence of chronic disorders, developed healthcare infrastructure, growing health awareness among patients and presence of key manufacturers of erectile dysfunction treatment drugs. Erectile dysfunction treatment drugs market in Europe is predicted to be driven by increasing prevalence of erectile dysfunction, growing awareness among target population and stiff competitions among drug manufacturers. Asia Pacific is anticipated to witness the lucrative growth as a result of growing health awareness among consumer, developing healthcare infrastructure and evolving market players.
Market Competition Assessment:
The erectile dysfunction treatment drugs market presently contains multiple companies with commercialized products across different geographies. New innovative products are being developed by various manufacturers and the market is expanding on account of increasing adoption and accessibilities of these products, growing popularity of brands and increasing prevalence of erectile dysfunction. The foremost industry players include Apricus Biosciences, Bayer AG, Dong-A Pharmaceutical Co. Ltd, Eli Lilly and Company, Johnson & Johnson Services, Meda Pharmaceuticals, Pfizer Inc., Vivus, Inc., and others.
Key Market Movements:
  • The increasing prevalence of erectile dysfunction due to growing prevalence of  chronic diseases, growing awareness of public regarding to improved health, increasing expenditure in R&D for generic drug production, broader range of pipeline drugs drive erectile dysfunction treatment drugs market
  • Patent expiration of branded drugs and lack of awareness among public in developing nations acted as restraining factors of the erectile dysfunction treatment drugs market
Table of Content
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Erectile Dysfunction Treatment Drugs Market Portraiture
2.1.1. Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2016 (US$ Mn)
2.1.2. Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2016 Vs. 2025 (Value %)......
Company Profiles
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Labels:

Comments

Post a Comment

Popular posts from this blog

Global Liquid Biopsy Market Dynamics, Forecast, Analysis and Supply Demand 2022: Credence Research

According to the latest report published by Credence Research, Inc. “ Liquid Biopsy Market   Growth, Future Prospects and Competitive Analysis, 2016-2022,” the liquid biopsy market was valued at USD 1,881.9 Mn in 2015, and is expected to reach USD 10,850.3 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022. Browse the full report Liquid Biopsy: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at  http://www.credenceresearch.com/report/liquid-biopsy-market Market Insights In the past, tissue samples extracted through biopsy were evaluated to detected malignancy. However, some micrographs delivered inconsistent and ambiguous results, thus demanding repeated procedure. The advent of molecular diagnostics and next generation sequencing offered pathologists with a powerful tool for efficient diagnosis. Even with such advances, cancer diagnosis still remained subject to the limitation of availability of biopsied tissue, which fu...
Post a Comment
Read more

Global Rigid Plastic Packaging Market Is Expected To Reach US$ 320.74 Bn by 2025: Strong Demand In Major Asia-Pacific Economies And Increasing Demand From Food & Beverage Packaging Industries: Credence Research

The latest market report published by Credence Research, Inc. “ Rigid Plastic Packaging Market  By Resin Type (Polyethylene, Polyethylene Terephthalate, Polypropylene, Polystyrene, Polyvinyl Chloride, Expanded Polystyrene, Others), By End-use industry (Beverages, Food, Healthcare, Personal Care, Industrial, Others), By Type (Bottles & Jars, Trays, Tubs Cups & Pots, Rigid Bulk Products and Others) and By Region (North America, Europe, Asia Pacific, Latin America, & Middle East & Africa) - Growth, Future Prospects and Competitive Analysis, 2017 - 2025,” the global rigid plastic packaging market was valued at US$ 195.56 Bn in 2016, expanding at a CAGR of 5.7% from 2017 to 2025. Browse the full report Rigid Plastic Packaging Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at  http://www.credenceresearch.com/report/rigid-plastic-packaging-market Market Insights Rigid plastic packaging possesses features such...
Post a Comment
Read more

Global Parenteral Nutrition Market to Reach Worth USD 28.2 Bn by 2022: Major Drivers Include Growing Malnutrition and Chronic Diseases Statistics and Geriatric Population: Credence Research

According to the latest report published by Credence Research, Inc. “ Parenteral Nutrition Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  global parenteral nutrition market was valued at USD 4,553.2 Mn in 2015, and is expected to reach USD 6,638.0 Mn by 2022, expanding at a CAGR of 5.5% from 2016 to 2022. Browse the full report Parenteral Nutrition Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at  http://www.credenceresearch.com/report/parenteral-nutrition-market Market Insights: The global parenteral nutrition market is anticipated to cross the 6 Bn mark by 2022. Growing prevalence of malnutrition and chronic conditions along with escalation in the geriatric population pool have key impact on driving this market. Additionally, perpetual growth in birth rates and premature births will also further support the growth of this market. Growing awareness about parenteral nutr...
Post a Comment
Read more